Composition for treating hbv infection
AssigneeTransgene S.A.
InventorsPerrine Martin, Geneviève Inchauspe, Nathalie Silvestre, Doris Schmitt, Alexei Evlachev
Life of this patent
Estimating the term…
Loading patent…
AssigneeTransgene S.A.
InventorsPerrine Martin, Geneviève Inchauspe, Nathalie Silvestre, Doris Schmitt, Alexei Evlachev
Estimating the term…
The present invention provides a composition comprising hepatitis B virus (HBV) component(s), and which may be either nucleic acid- or polypeptide-based as well as nucleic acid molecules and vectors encoding such HBV component(s). It also relates to infectious viral particles and host cells comprising such nucleic acid molecules or vectors. It also provides composition and kits of parts comprising such nucleic acid molecules, vectors, infectious viral particles or host cells and the therapeutic use thereof for preventing or treating HBV infections.
An immunogenic composition comprising at least one polypeptide or a nucleic acid molecule encoding said at least one polypeptide, wherein said at least one polypeptide is selected from the group consisting of:
A host cell comprising the nucleic acid molecule according to claim 30 or claim 31, the vector according to claim 32 or the infectious viral particle according to claim 42 or claim 43.
Dependencies are inferred from the claim text.